Cargando…

N‐glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome

Particular N‐glycan structures are known to be associated with breast malignancies by coordinating various regulatory events within the tumor and corresponding microenvironment, thus implying that N‐glycan patterns may be used for cancer stratification and as predictive or prognostic biomarkers. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terkelsen, Thilde, Haakensen, Vilde D., Saldova, Radka, Gromov, Pavel, Hansen, Merete Kjær, Stöckmann, Henning, Lingjærde, Ole Christian, Børresen‐Dale, Anne‐Lise, Papaleo, Elena, Helland, Åslaug, Rudd, Pauline M., Gromova, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983225/ https://www.ncbi.nlm.nih.gov/pubmed/29698574 http://dx.doi.org/10.1002/1878-0261.12312

Ejemplares similares

High‐throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype‐specific serologically relevant biomarkers
por: Terkelsen, Thilde, et al.
Publicado: (2021)

Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration
por: Terkelsen, Thilde, et al.
Publicado: (2020)

Profiling of microRNAs in tumor interstitial fluid of breast tumors – a novel resource to identify biomarkers for prognostic classification and detection of cancer
por: Halvorsen, Ann Rita, et al.
Publicado: (2016)

Serum N‐glycome alterations in breast cancer during multimodal treatment and follow‐up
por: Saldova, Radka, et al.
Publicado: (2017)

PathTracer: High-sensitivity detection of differential pathway activity in tumours
por: Nygård, Ståle, et al.
Publicado: (2019)

Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
por: Langberg, Christian Wilhelm, et al.
Publicado: (2023)

Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors
por: Rye, Inga H., et al.
Publicado: (2018)

Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas
por: Haakensen, Vilde D, et al.
Publicado: (2011)

Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density
por: Haakensen, Vilde D, et al.
Publicado: (2010)

Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling
por: Gilgunn, Sarah, et al.
Publicado: (2020)

Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
por: Khadse, Anand, et al.
Publicado: (2022)

Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity
por: Dannenfelser, Ruth, et al.
Publicado: (2017)

Greedy feature selection for glycan chromatography data with the generalized Dirichlet distribution
por: Galligan, Marie C, et al.
Publicado: (2013)

CAncer bioMarker Prediction Pipeline (CAMPP)—A standardized framework for the analysis of quantitative biological data
por: Terkelsen, Thilde, et al.
Publicado: (2020)

Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features
por: Haakensen, Vilde D, et al.
Publicado: (2011)

Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics
por: Jabeen, Shakila, et al.
Publicado: (2018)

Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis
por: Fleischer, Thomas, et al.
Publicado: (2014)

N-glycans from serum IgG and total serum glycoproteins specific for endometriosis
por: Kovács, Zsuzsanna, et al.
Publicado: (2023)

Comprehensive N-Glycan Profiling of Avian Immunoglobulin Y
por: Gilgunn, Sarah, et al.
Publicado: (2016)

Fibroblast Growth Factor Receptor 3 (FGFR3)–Analyses of the S249C Mutation and Protein Expression in Primary Cervical Carcinomas
por: Dai, Haiyan, et al.
Publicado: (2001)

Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level
por: Kønig, Simon Mathis, et al.
Publicado: (2019)

Molecular characterisation of TP53 mutated squamous cell carcinomas of the lung to identify putative targets for therapy
por: Haakensen, Vilde D., et al.
Publicado: (2020)

Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response
por: Lucchetta, Marta, et al.
Publicado: (2019)

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma
por: Haakensen, Vilde Drageset, et al.
Publicado: (2021)

Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors
por: Bjaanæs, Maria Moksnes, et al.
Publicado: (2021)

Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease
por: Eide, Hanne Astrid, et al.
Publicado: (2016)

Neurotensin Receptor 1 Is Expressed in Gastrointestinal Stromal Tumors but Not in Interstitial Cells of Cajal
por: Gromova, Petra, et al.
Publicado: (2011)

The multitude of molecular analyses in cancer: the opening of Pandora’s box
por: Russnes, Hege G, et al.
Publicado: (2014)

Glycosylation Changes on Serum Glycoproteins in Ovarian Cancer May Contribute to Disease Pathogenesis
por: Saldova, Radka, et al.
Publicado: (2008)

Atezolizumab and stereotactic body radiotherapy in patients with advanced non‐small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT‐1 trial
por: Horndalsveen, Henrik, et al.
Publicado: (2022)

Identification and characterization of O-linked glycans in cervical mucus as biomarkers of sperm transport: A novel sheep model
por: Abril-Parreño, Laura, et al.
Publicado: (2021)

Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
por: Mimura, Yusuke, et al.
Publicado: (2022)

High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival
por: Baumbusch, Lars O., et al.
Publicado: (2013)

Linear and non-linear dependencies between copy number aberrations and mRNA expression reveal distinct molecular pathways in breast cancer
por: Solvang, Hiroko K, et al.
Publicado: (2011)

TP53 mutations among molecular subtypes of HER2-positive tumors
por: Helland, Å, et al.
Publicado: (2005)

Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened Prognosis
por: Murph, Mandi M., et al.
Publicado: (2009)

TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients
por: Halvorsen, Ann R., et al.
Publicado: (2016)

Shotgun Glycomics Identifies Tumor-Associated Glycan Ligands Bound by an Ovarian Carcinoma-Specific Monoclonal Antibody
por: Liau, B., et al.
Publicado: (2017)

Exploring the Glycosylation of Serum CA125
por: Saldova, Radka, et al.
Publicado: (2013)

Tumor-Associated Glycans and Immune Surveillance
por: Monzavi-Karbassi, Behjatolah, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bt9f7h9vn5ko18ucennhp03hm1